Abstract
In this chapter we explain:
-
How serum creatinine is related to glomerular filtration rate (GFR)
-
The limitations of creatinine as a measure of GFR
-
How GFR is estimated from serum creatinine and cystatin C
-
Common errors made when using eGFR
-
How to interpret urea and creatinine together
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Serum Creatinine
- Glomerular Filtration rateGlomerular Filtration Rate
- Polycystic Kidney Disease
- Serum Urea
- Serum Creatinine Concentration
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
How Can Kidney Function Be Measured?
To assess someone’s kidney function, one would really like to measure their glomerular filtration rate (GFR). This can be done using a radioisotope tracer that is cleared from the blood solely by glomerular filtration, such as Cr-51 EDTA or Tc-99m DTPA. This technique is useful for research and when precise measurements of GFR are required. But it is impractical for routine repeated measurements.
Instead of measuring the clearance of an artificial tracer, routine assessment of kidney function uses the concentration of a substance produced by the body, creatinine, urea or cystatin C. Their concentration is determined by the balance between the rate of production and the rate of excretion.
When production and excretion have been stable for more than 24 h, an equilibrium concentration is reached. In equilibrium, the concentration is not affected by the volume of body water in which the substance is dissolved. Patients who are chronically fluid overloaded do not have a lower concentration due to dilution. The higher concentration found with dehydration is due to reduced kidney function, not haemoconcentration.
Creatinine would be the ideal choice for measuring kidney function if it was produced at a constant rate, freely filtered by the glomeruli, and neither reabsorbed nor secreted by the tubules. Unfortunately, it does not pass all these tests.
Creatinine is released into the bloodstream at a fairly constant rate from the breakdown of creatine in healthy skeletal muscles and is freely filtered by the glomeruli. In addition, 10–20 % of normal total creatinine excretion is by secretion into the tubules. As GFR declines that proportion increases and so serum creatinine does not increase as much as predicted from filtration. This is shown by comparing simultaneous measurements of serum creatinine and GFR using the gold standard inulin clearance technique (see Fig. 2.1).
The curved relationship between creatinine and GFR makes changes in serum creatinine hard to interpret correctly. Figure 2.2 shows a graph of serum creatinine against time in a man with declining kidney function. The shape of the line suggests that the rate of loss of kidney function accelerates over the years.
If we now add in GFR values, it is clear that kidney function has actually declined at a constant rate over the whole period (see Fig. 2.3).
Because of the inverse curved relationship between GFR and creatinine, the drop in GFR from 116 to 60 during the first 5 years causes a smaller increase in serum creatinine than the decline from 60 to 30 over the next 3 years.
How Can GFR Be Estimated from Serum Creatinine?
To make serum creatinine results easy to interpret we need to convert them into estimates of the GFR (eGFR ). Equations to do the conversion have been derived from databases containing simultaneous measurements of GFR, by a radioisotope clearance technique, and serum creatinine concentration. The four-variable MDRD equation was derived from measurements performed on adult patients with chronic kidney disease in the Modification of Diet in Renal Disease (MDRD) study [2].
eGFR values are standardised to a body surface area of 1.73 m2 and so their calculation does not require the patient’s body weight. This makes it possible for the laboratory to provide eGFR values automatically from the patient’s age and sex. As the laboratory does not usually have reliable information about ethnicity, the adjustment for Afro-Caribbean race is done manually.
The MDRD Equation [2]
For serum creatinine values in mg/dL, the equation is:
This equation uses serum creatinine values calibrated against isotope dilution mass spectrometry (IDMS).
For children, different equations are available [3]. The commonest used is the Schwarz equation [4].
The Schwarz Equation [4]
Are These Estimates Accurate and Reliable?
The 90 % confidence intervals of the estimates are wide. Using the MDRD equation, 90 % of estimates are within 30 % of the directly measured GFR and 98 % within 50 %. In children using the Schwarz equation, 80 % of estimates are within 30 % of the measured GFR. The estimates are less accurate in people with very abnormal body composition, such as amputees and malnourished patients.
The MDRD equation was derived from patients known to have kidney disease and a raised serum creatinine. It is inaccurate for estimating GFR from serum creatinine values in the normal range, i.e. outside the dataset used to derive the formula, for example in pregnancy [5]. The eGFR is not appropriate for situations in which a more accurate measurement of GFR is required, such as in the assessment of a potential transplant donor.
Because the MDRD equation underestimates the true GFR when serum creatinine values are in the normal range, people are at risk of being labelled as having kidney disease based upon these estimates. To reduce this, guidelines recommend that laboratories use the more recently developed CKD-EPI equations [6]. CKD-EPI gives estimates that are closer to the measured GFR at lower levels of serum creatinine, applying a different equation when creatinine is in the normal range [7, 8].
The CKD-EPI Equations [7]
Black
-
Female
-
$$ \mathrm{Serum}\;\mathrm{creatinine} $$
-
$$ \le 62\kern0.24em \upmu \mathrm{mol}/\mathrm{L}\left(\le 0.7\kern0.24em \mathrm{mg}/\mathrm{dL}\right)\kern1.34em \mathrm{G}\mathrm{F}\mathrm{R}=166\times {\left(\mathrm{S}\mathrm{c}\mathrm{r}/0.7\right)}^{-0.329}\times {(0.993)}^{\mathrm{Age}} $$
-
$$ >62\;\upmu \mathrm{mol}/\mathrm{L}\left(>0.7\kern0.24em \mathrm{mg}/\mathrm{dL}\right)\kern1.34em \mathrm{G}\mathrm{F}\mathrm{R}=166\times {\left(\mathrm{S}\mathrm{c}\mathrm{r}/0.7\right)}^{-1.209}\times {(0.993)}^{\mathrm{Age}} $$
-
-
Male
-
$$ \le 80\;\left(\le 0.9\right)\kern1.34em \mathrm{G}\mathrm{F}\mathrm{R}=163\times {\left(\mathrm{S}\mathrm{c}\mathrm{r}/0.9\right)}^{-0.411}\times {(0.993)}^{\mathrm{Age}} $$
-
$$ >80\;\left(>0.9\right)\kern1.34em \mathrm{G}\mathrm{F}\mathrm{R}=163\times {\left(\mathrm{S}\mathrm{c}\mathrm{r}/0.9\right)}^{-1.209}\times {(0.993)}^{\mathrm{Age}} $$
-
White or other ethnicity
-
Female
-
$$ \le 62\;\left(\le 0.7\right)\kern1.34em \mathrm{G}\mathrm{F}\mathrm{R}=144\times {\left(\mathrm{S}\mathrm{c}\mathrm{r}/0.7\right)}^{-0.329}\times {(0.993)}^{\mathrm{Age}} $$
-
$$ >62\;\left(>0.7\right)\kern1.34em \mathrm{G}\mathrm{F}\mathrm{R}=144\times {\left(\mathrm{S}\mathrm{c}\mathrm{r}/0.7\right)}^{-1.209}\times {(0.993)}^{\mathrm{Age}} $$
-
-
Male
-
$$ \le 80\;\left(\le 0.9\right)\kern1.34em \mathrm{G}\mathrm{F}\mathrm{R}=141\times {\left(\mathrm{S}\mathrm{c}\mathrm{r}/0.9\right)}^{-0.411}\times {(0.993)}^{\mathrm{Age}} $$
-
$$ >80\;\left(>0.9\right)\kern1.34em \mathrm{G}\mathrm{F}\mathrm{R}=141\times {\left(\mathrm{S}\mathrm{c}\mathrm{r}/0.9\right)}^{-1.209}\times {(0.993)}^{\mathrm{Age}} $$
-
CKD-EPI = Chronic Kidney Disease Epidemiology Collaboration
Scr = serum creatinine in mg/dL (micromol/L/88.4)
Age in years for ≥18
It is best to use the eGFR estimate provided by the laboratory that analysed the blood sample as that will include appropriate adjustments for the creatinine assay.
The accuracy of GFR estimates is less relevant when they are used to follow an individual patient over time. Here it is the shape of the graph rather than the exact value that is of interest. There is a good correlation between the slopes of measured and estimated GFR values over time. Also, patient-related factors affect the measured and estimated GFR slopes in a similar way, so slopes can be compared between patients [9, 10].
One way to validate the use of eGFR graphs is to compare them with graphs of measured GFR in patients with similar pathological processes. Figure 2.4 shows sequential measurements of GFR from five patients with autosomal dominant polycystic kidney disease (ADPKD). The trajectory of GFR is linear, although the gradient varies between patients.
Graphs of estimated GFR from patients with ADPKD also have linear trajectories (see Fig. 2.5).
Interpreting eGFR Values
eGFR equations for men and women are different because, on average, men contain proportionately more muscle than women. Body composition also changes with age, the proportion of muscle declining as people grow older. Including these factors, we can draw a family of graphs of estimated GFR versus serum creatinine (see Fig. 2.6).
Females have a lower eGFR than males for any given serum creatinine value (see Fig. 2.7).
To derive the correct eGFR, the laboratory must be provided with the correct sex and date of birth. Using an incorrect adjustment causes a significant error in the estimate, giving either false alarm or false reassurance, as shown by the following cases (Patients 2.1 and 2.2).
Patient 2.1: Biochemical ‘Sex Change’
Mr Edwards was shocked to be told by his GP that he needed to go back to the kidney clinic and talk about possible dialysis because his kidney function had suddenly dropped from 25 to 18 (see Fig. 2.8).
Careful study of the laboratory report revealed the mistake:
Patient: 123456 John Edwards
Date of Birth 14/08/1948Female
Sample B,13.0763622 (BLOOD)Collected 16 Jun 2013 08:00 Received 16 Jun 2013 12:00
Urea & Electrolytes
Sodium 141mmol/L(133 - 146)
Potassium5.0mmol/L(3.5 - 5.3)
Urea*19.6 mmol/L(2.5 - 7.8)
Creatinine*235μmol/L(50 - 98)
Estimated GFR* 18 ml/min/1.73m 2
Patients with family names that are also used as first names are at particular risk of being labelled with the wrong sex (Patient 2.2).
Patient 2.2: Biochemical ‘Sex-Change’
Mrs Tracey Paul was delighted to be told at her routine diabetes clinic review that her kidney function had improved (see Fig. 2.9).
Unfortunately, the good news was an error; her kidney was declining after all. The error was picked up when a doctor questioned how serum creatinine and eGFR had both increased. Here is her laboratory report:
Patient: 234567Tracey Paul
Date of Birth 02/07/1937Male
Sample B, 13.0343712 (BLOOD)Collected 15 Apr 2014 Received 15 Apr 2014 15:38
Urea & Electrolytes
Sodium139mmol/L(133 - 146)
Potassium 4.9mmol/L(3.5 - 5.3)
Urea* 16.7 mmol/L(2.5 - 7.8)
Creatinine* 144μmol/L(50 - 98)
Estimated GFR* 41ml/min/1.73m 2
Previous results:
Date | Sodium | Potassium | Urea | Creatinine | eGFR |
15.01.2014 | 141 | 5.0 | 14.8 | 126 | 37 |
The estimated GFR needs to be adjusted for Afro-Caribbean race but not for other ethnicities (see Fig. 2.10). This is because of genetically determined differences in skeletal muscle between racial groups. Compared to white Caucasians, black African people have 30–40 % higher activities of a number of enzymes involved in phosphagenic metabolic pathways, including creatine kinase [12].
Not All Changes in Serum Creatinine Are Caused by Changes in GFR
Changes in serum creatinine do not necessarily indicate changes in glomerular filtration. Three other factors affect the serum creatinine concentration: dietary creatinine, muscle mass and secretion of creatinine by the tubules.
Dietary Creatinine
Little creatinine is absorbed from meat in a usual diet. However, meat that has been boiled, such as in goulash, leads to a rise in creatinine that lasts 8 h. Dietary supplements, such as protein shakes and creatine, do not alter GFR [13] but there can be a transient increase in serum creatinine with excessive amounts. People who use these supplements do so to increase their muscle mass. Therefore it can be hard to work out whether a high serum creatinine level is due to the creatine supplements, a high muscle mass, reduced GFR, or a combination of all three.
In this situation, it is helpful to use an alternative maker of glomerular filtration to creatinine, namely cystatin C [14]. Cystatin C is a small protein comprising 120 amino acids that is produced by all nucleated cells, not just muscle. Its function is to inhibit enzymes that break down proteins, in particular extracellular cysteine proteases. It is freely filtered by glomeruli and then reabsorbed by the tubules; only small amounts are excreted in the urine.
Equations based upon cystatin C give a more accurate estimate of GFR when it is in the normal range and so are useful for distinguishing whether a raised serum creatinine is due to large muscle mass alone or a reduced GFR.
Patient 2.3: Big Muscles or Small Kidneys?
Emershan was a fit and healthy 33 year old black man. He had been a successful athlete, specialising in sprint distances. He had had his U&E’s checked as part of a number of tests for chest pains, for which no cause was ever found. These were the results (Table 2.1).
Estimated GFR was 55 ml/min/1.73 m2 (adjusted for black race)
His blood pressure was normal and urinalysis showed no blood or protein. Urinary albumin:creatinine ratio was 0.2 mg/mmol. A kidney ultrasound scan was normal.
He ate a normal diet with no creatine supplements.
He was anxious that he may have a kidney disease. To resolve the issue, serum cystatin C was measured. The result, 0.93 mg/L, gave an eGFR using the CKD-EPI Cystatin C (2012) equation of 95 ml/min/1.73 m2. He was reassured.
Changes in Muscle Mass
Creatinine production is proportional to a patient’s skeletal muscle mass. If a patient loses or gains a lot of muscle, the serum creatinine concentration will change independently of GFR. For example, patients who are seriously ill requiring care in an intensive therapy unit (ITU) can lose a substantial amount of body weight. As a result, their serum creatinine can be up to one-third lower after the illness. This reduces the apparent number of patients left with kidney damage on discharge from the ITU, and the severity of that damage as estimated from their serum creatinine [15].
Tubular Secretion of Creatinine
The equations used to estimate GFR take the tubular secretion of creatinine into account. However, problems arise when a patient is given a drug that blocks secretion of creatinine by the tubules. The most commonly used drug that does this is the antibiotic trimethoprim [16]. The anti-arrhythmic dronedarone has the same effect is some patients [17].
Treatment with these drugs will cause the eGFR to drop, even though the true GFR has not changed.
Patient 2.4: The Trimethoprim Effect
Rick, a longstanding kidney transplant patient receiving ciclosporin and prednisolone, was troubled by recurrent Escherichia coli urinary infections. These responded well to long-term treatment with alternating courses of trimethoprim and cephalexin. Each time Rick took trimethoprim the eGFR dropped and he was worried that his transplant was being damaged (Table 2.2).
The serum urea was the clue that the tubular effect of trimethoprim was causing a rise in creatinine. It did not rise with the serum creatinine, suggesting that the true GFR was unchanged.
Serum Urea and Creatinine – Different Measuresof Kidney Function
Changes in serum urea can give useful additional information about what is happening to kidney function. Urea and creatinine are both filtered by the glomeruli but only urea can diffuse across cell membranes and be reabsorbed from the tubules.
The amount of urea reabsorbed is determined by the rate of flow of filtrate along the nephron. When the rate slows, more urea is reabsorbed and the rate of excretion falls (see Fig. 2.11).
How does this difference affect a patient’s results? Consider two people: one with polycystic kidneys (ADPKD), the other with normal kidneys but low blood pressure due to prolonged diarrhoea. In the man with ADPKD, half of the nephrons have been affected by cysts and do not function – his GFR is half-normal. However, the rate of flow of filtrate in the functioning nephrons is normal and he produces a normal volume of urine per day.
In the man with low blood pressure, the nephrons are filtering at half the normal rate – his GFR is also half-normal. To compensate for the hypovolaemia, salt and water are reabsorbed from the tubules into the blood and the flow of filtrate along the nephrons is slow. Urine volume is reduced.
Because the glomerular filtration rate is halved, the concentration of creatinine is doubled in both patients. However, in the second patient, the slower flow of filtrate along the nephrons allows more urea to diffuse out of the tubules into the blood. As a result, the serum urea concentration is higher in the second patient than in the first.
Calculating the ratio of serum urea to serum creatinine shows this effect (Table 2.3).
A urea-to-creatinine ratio >100 (BUN-to-creatinine ratio >20) is often said to indicate dehydration but can occur in any situation in which the flow of filtrate along the nephrons is slowed. It is a marker of a pre-renal or, more precisely, pre-glomerular cause of kidney impairment.
References
Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985;28(5):830–8. http://www.nature.com/ki/journal/v28/n5/pdf/ki1985205a.pdf.
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–70. PubMed: 10075613. http://annals.org/article.aspx?articleid=712617.
Schwartz GJ, Work DF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol. 2009;4(11):1832–43. doi:10.2215/CJN.01640309. Published ahead of print October 9, 2009. http://cjasn.asnjournals.org/content/4/11/1832.full.
Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20:629–37. doi:10.1681/ASN.2008030287. http://jasn.asnjournals.org/content/20/3/629.full.
Smith M, Moran P, Ward M, Davison J. Assessment of glomerular filtration rate during pregnancy using the MDRD formula. BJOG. 2008;115:109–12. http://onlinelibrary.wiley.com/doi/10.1111/j.1471-0528.2007.01529.x/full.
KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. www.kdigo.org/clinical_practice_guidelines/pdf/CKD/KDIGO_2012_CKD_GL.pdf; www.nice.org.uk/guidance/CG182/chapter/introduction.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro 3rd AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763564/.
Kilbride HS, Stevens PE, Eaglestone G, Knight S, Carter JL, Delaney MP, Farmer CK, Irving J, O’Riordan SE, Dalton RN, Lamb EJ. Accuracy of the MDRD (Modification of Diet in Renal Disease) study and CKD-EPI (CKD Epidemiology Collaboration) equations for estimation of GFR in the elderly. Am J Kidney Dis. 2013;61(1):57–66. doi:10.1053/j.ajkd.2012.06.016. Epub 2012 Aug 11. http://www.ajkd.org/article/S0272-6386(12)00941-9/abstract.
Xie D, Joffe MM, Brunelli SM, Beck G, Chertow GM, Fink JC, Greene T, Hsu C-Y, Kusek JW, Landis R, Lash J, Levey AS, O’Conner A, Ojo A, Rahman M, Townsend RR, Wang H, Feldman HI. A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease. Clin J Am Soc Nephrol. 2008;3(5):1332–8. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518808/.
Padala S, Tighiouart H, Inker LA, Contreras G, Beck GJ, Lewis J, Steffes M, Rodby RA, Schmid CH, Levey AS. Accuracy of a GFR estimating equation over time in people with a wide range of kidney function. Am J Kidney Dis. 2012;60(2):217–24. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399947/.
Franz KA, Reubl FC. Rate of functional deterioration in polycystic kidney disease. Kidney Int. 1983;23:526–9. http://www.nature.com/ki/journal/v23/n3/pdf/ki198351a.pdf.
Ama PF, Simoneau JA, Boulay MR, Serresse O, Thériault G, Bouchard C. Skeletal muscle characteristics in sedentary black and Caucasian males. J Appl Physiol (1985). 1986;61(5):1758–61. http://jap.physiology.org/content/61/5/1758.
Lugaresi R, Leme M, de Salles Painelli V, Murai IH, Roschel H, Sapienza MT, Herbert Lancha AH, Gualano B. Does long-term creatine supplementation impair kidney function in resistance-trained individuals consuming a high-protein diet? J Int Soc Sports Nutr. 2013;10:26. doi:10.1186/1550-2783-10-26. http://www.jissn.com/content/10/1/26.
Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, Rossert J, Van Lente F, Bruce RD, Zhang YL, Greene T, Levey AS. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD. Am J Kidney Dis. 2008;51(3):395–406. doi:10.1053/j.ajkd.2007.11.018. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2390827/.
Prowle JR, Kolic I, Purdell-Lewis J, Taylor R, Pearse RM, Kirwan CJ. Serum creatinine changes associated with critical illness and detection of persistent renal dysfunction after AKI. Clin J Am Soc Nephrol. 2014;9(6):1015–23. doi:10.2215/CJN.11141113. published ahead of print April 17, 2014, http://cjasn.asnjournals.org/content/9/6/1015.abstract.
Berg KJ, Gjellestad A, Nordby G, Rootwelt K, Djøseland O, Fauchald P, Mehl A, Narverud J, Talseth T. Renal effects of trimethoprim in ciclosporin- and azathioprine-treated kidney-allografted patients. Nephron. 1989;53(3):218–22. http://www.karger.com/Article/Abstract/185747.
Duncker D, Oswald H, Gardiwal A, Lüsebrink U, König T, Schreyer H, Klein G. Stable cystatin C serum levels confirm normal renal function in patients with dronedarone-associated increase in serum creatinine. J Cardiovasc Pharmacol Ther. 2013;18(2):109. http://cpt.sagepub.com/content/18/2/109.abstract.
Van Slyke DD. The effect of urine volume on urea excretion. J Clin Invest. 1947;26:1159–67. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC439461/pdf/jcinvest00386-0111.pdf.
Austin JH, Stillman E, Van Slyke DD. Factors governing the excretion rate of urea. J Biol Chem. 1921;46:91–112. http://www.jbc.org/content/46/1/91.full.pdf.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Rayner, H., Thomas, M., Milford, D. (2016). Measuring Kidney Function. In: Understanding Kidney Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-23458-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-23458-8_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23457-1
Online ISBN: 978-3-319-23458-8
eBook Packages: MedicineMedicine (R0)